Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Atritech lands $22m in financing:

This article was originally published in Clinica

Executive Summary

Developer of the Watchman left atrial appendage system Atritech has closed a $22m round of financing. This round, which was led by SightLine Partners, brings Atritech's total funding over the last 18 months to $45m. The Plymouth, Minnesota-based firm said it will use the proceeds to complete clinical trials of its lead product, which is designed to prevent patients with atrial fibrillation from suffering a stroke by keeping blood clots from forming in the heart.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel